Myozyme and flushing 
Myozyme and flushing Patient Reports February 12, 2012
Myozyme Side Effects Report #5677967-7
Myozyme side effect was reported by a Health Professional from UNITED STATES on Mar 05, 2008. Female patient, child 9 years of age, weighting 66.14 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anxiety
, chest discomfort, cyanosis, dyspnoea, eye swelling, flushing, hypersensitivity, nausea , pallor. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with FLONASE, CONCERTA, ALBUTEROL. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5796386-6
Myozyme side effect was reported by a Physician from UNITED STATES on June 19, 2008. Female patient, child 9 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: arthralgia, blood immunoglobulin g increased, catheter site erythema, catheter site pruritus, cough, dyspnoea, flushing, headache
. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with PREDNISONE, BENADRYL. Patient recovered.Myozyme Side Effects Report #5799564-5
Myozyme side effect was reported by a Health Professional from UNITED STATES on June 20, 2008. Female patient, child 9 years of age, weighting 66.14 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anxiety
, aphasia , blood pressure increased, chest discomfort, cyanosis, dyspnoea, eye swelling, flushing, hypersensitivity. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with FLONASE, CONCERTA, ALBUTEROL. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5832451-2
Myozyme side effect was reported by a Physician from UNITED STATES on July 21, 2008. Female patient, child 9 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: arthralgia, chest discomfort, cough, cyanosis, dysgeusia, dyspnoea, face oedema, flushing, headache
. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with PREDNISONE, BENADRYL. Patient recovered.Myozyme Side Effects Report #6055334-4
Myozyme side effect was reported by a Physician from UNITED STATES on Jan 02, 2009. Female patient, child 9 years of age, weighting 66.14 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anxiety
, blood pressure increased, chest discomfort, circumoral oedema, cyanosis, dyspnoea, eye swelling, flushing, hypersensitivity. Myozyme dosage: 20 MG/KG, Q2W; INTRAVENOUS. During the same period patient was treated with FLONASE, CONCERTA, ALBUTEROL. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #6081262-4
Myozyme side effect was reported by a Physician from UNITED STATES on Feb 03, 2009. Male patient, 60 years of age, weighting 264.6 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: angioedema, arthralgia, blood pressure increased, chest discomfort, chills, dyspepsia, flushing, headache
, infusion related reaction. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with LORATADINE, METHYLSULFONYLMETHANE, DARVOCET, SYNTHROID, FELDENE, SULAR, CLONIDINE, HYDROCHLOROTHIAZIDE. Patient recovered.Myozyme Side Effects Report #5853417-2
Myozyme side effect was reported by a Physician from ISRAEL on Aug 06, 2008. Female patient, child 6 years of age, weighting 44.09 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: activities of daily living impaired, chills, face oedema, fatigue, flushing, heart rate increased, hypersensitivity, infusion related reaction, nonspecific reaction. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient recovered.
Myozyme Side Effects Report #5942624-6
Myozyme side effect was reported by a Physician from ISRAEL on Oct 22, 2008. Female patient, child 6 years of age, weighting 39.68 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal pain
, asthenia, chills, developmental delay, diarrhoea, face oedema, fatigue, flushing, immunology test abnormal. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient recovered.Myozyme Side Effects Report #5950872-4
Myozyme side effect was reported by a Physician from ISRAEL on Oct 29, 2008. Female patient, child 6 years of age, weighting 44.09 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure diastolic decreased, blood pressure systolic increased, chills, dizziness
, exposure to communicable disease, face oedema, fatigue, flushing, heart rate increased. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient recovered.Myozyme Side Effects Report #5424565-6
Myozyme side effect was reported by a Physician from UNITED KINGDOM on June 19, 2007. Female patient, 56 years of age, weighting 183.0 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chest discomfort, chills, feeling hot, flushing, peripheral circulatory failure. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with FLECAINIDE ACETATE, AMITRIPTYLINE, PARACETAMOL, FEMOSTON, FERROUS GLOCUNATE. Patient recovered.
Myozyme Side Effects Report #5582791-X
Myozyme side effect was reported by a Physician from ITALY on Dec 17, 2007. Female patient, 49 years of age, weighting 128.1 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chest discomfort, chest pain
, circumoral oedema, flushing, paraesthesia, paraesthesia oral, pruritus, refusal of treatment by patient. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5775965-6
Myozyme side effect was reported by a Physician from UNITED STATES on May 30, 2008. Female patient, 48 years of age, weighting 165.8 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure increased, chest discomfort, dyspnoea, flushing, hypersensitivity, throat tightness. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, SYNTHROID, VESICARE, ZOLOFT. Patient recovered.
Myozyme Side Effects Report #5933430-7
Myozyme side effect was reported by a Physician from UNITED STATES on Oct 16, 2008. Female patient, 48 years of age, weighting 165.3 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure increased, chest discomfort, dyspnoea, flushing, hypersensitivity, throat tightness. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, SYNTHROID, VESICARE, ZOLOFT. Patient recovered.
Myozyme Side Effects Report #5216727-8
Myozyme side effect was reported by a Consumer or non-health professional from FRANCE on Jan 04, 2007. Female patient, 45 years of age, weighting 123.5 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, back pain
, blood pressure decreased, chest discomfort, chest pain , erythema, flushing, infusion related reaction, nausea . Myozyme dosage: unknown. During the same period patient was treated with FERROUS SULPHATE, POLARAMINE, TELFAST. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5192529-6
Myozyme side effect was reported by a Physician from FRANCE on Dec 06, 2006. Female patient, 45 years of age, weighting 123.5 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anaphylactic shock, back pain
, chest discomfort, chest pain , flushing, nausea , oedema, respiratory disorder, skin discolouration. Myozyme dosage: unknown. During the same period patient was treated with FERROUS SULPHATE, POLARAMINE, TELFAST. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5154555-2
Myozyme side effect was reported by a Consumer or non-health professional from FRANCE on Oct 31, 2006. Female patient, 44 years of age, weighting 123.5 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: back pain
, blood pressure decreased, chest pain , erythema, face oedema, flushing, hypotension. Myozyme dosage: unknown. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5332845-8
Myozyme side effect was reported by a Physician from GREECE on May 11, 2007. Female patient, 40 years of age, weighting 121.3 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: erythema, flushing, infusion related reaction, lower respiratory tract infection, no therapeutic response, oedema peripheral, pharyngitis, pseudomonas infection, sputum culture positive. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5285768-7
Myozyme side effect was reported by a Pharmacist from UNITED STATES on Oct 02, 2006. Male patient, 38 years of age, weighting 137.3 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: feeling hot, flushing, hyperhidrosis, oedema peripheral, palmar erythema, pruritus, skin tightness, urticaria. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with TYLENOL. Patient recovered.
Myozyme Side Effects Report #5336329-2
Myozyme side effect was reported by a Physician from UNITED STATES on May 09, 2007. Female patient, 33 years of age, weighting 160.9 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chest discomfort, dizziness
, dyspnoea, flushing, headache , hypersensitivity, nausea , oxygen saturation decreased, peak expiratory flow rate decreased. Myozyme dosage: 10 MG/KG QWK IV. During the same period patient was treated with PREDNISONE, SYNTHROID, NAPROXEN, HYDROCODONE BITARTRATE, HYDROCORTISONE. Patient recovered.Myozyme Side Effects Report #5945820-7
Myozyme side effect was reported by a Health Professional from UNITED KINGDOM on Oct 27, 2008. Female patient, 33 years of age, weighting 110.7 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, blood pressure increased, dyspnoea, feeling hot, flushing, heart rate increased. Myozyme dosage: 1000 MG, Q2W, INTRAVENOUS. Patient recovered.
Myozyme Side Effects Report #5945821-9
Myozyme side effect was reported by a Health Professional from UNITED KINGDOM on Oct 27, 2008. Female patient, 33 years of age, weighting 112.0 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure decreased, chest discomfort, cold sweat, flushing, malaise, pallor. Myozyme dosage: 1000 MG, Q2W, INTRAVENOUS. Patient recovered.
Myozyme Side Effects Report #5960897-0
Myozyme side effect was reported by a Health Professional from UNITED KINGDOM on Nov 12, 2008. Female patient, 33 years of age, weighting 110.7 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, blood pressure increased, dyspnoea, feeling hot, flushing, heart rate increased. Myozyme dosage: 1000 MG, Q2W, INTRAVENOUS. Patient recovered.
Myozyme Side Effects Report #6005617-9
Myozyme side effect was reported by a Health Professional from UNITED KINGDOM on Dec 08, 2008. Female patient, 33 years of age, weighting 112.9 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure increased, dizziness
, dyspnoea, feeling hot, flushing, heart rate decreased, heart rate increased, hypotension, immunology test abnormal. Myozyme dosage: 1000 MG/DAY, Q2W, INTRAVENOUS. During the same period patient was treated with CHLORPHENIRAMINE MALEATE, ACETAMINOPHEN. Patient recovered.Myozyme Side Effects Report #6081258-2
Myozyme side effect was reported by a Physician from UNITED STATES on Feb 02, 2009. Male patient, child 3 years of age, weighting 37.48 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: agitation, anxiety
, blood pressure decreased, bronchospasm, cyanosis, fatigue, feeding tube complication, flushing, heart rate increased. Myozyme dosage: 350 MG, Q2W, INTRAVENOUS. During the same period patient was treated with BENADRYL, ACETAMINOPHEN, DECADRON. Patient recovered.Myozyme Side Effects Report #6101010-9
Myozyme side effect was reported by a Physician from UNITED STATES on Feb 17, 2009. Male patient, child 3 years of age, weighting 37.48 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: agitation, anxiety
, blood pressure decreased, bronchospasm, cyanosis, fatigue, flushing, heart rate increased, hypoxia. Myozyme dosage: 350 MG, Q2W, INTRAVENOUS. During the same period patient was treated with BENADRYL, ACETAMINOPHEN, DECADRON. Patient recovered.Myozyme Side Effects Report #6125057-1
Myozyme side effect was reported by a Physician from UNITED STATES on Mar 05, 2009. Male patient, child 3 years of age, weighting 37.48 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: agitation, antibody test positive, anxiety
, blood pressure decreased, bronchospasm, cyanosis, fatigue, flushing, hypoxia. Myozyme dosage: 350 MG, Q2W, INTRAVENOUS. During the same period patient was treated with BENADRYL, ACETAMINOPHEN, DECADRON. Patient recovered.Myozyme Side Effects Report #6137899-7
Myozyme side effect was reported by a Physician from UNITED STATES on Mar 17, 2009. Male patient, child 3 years of age, weighting 37.48 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: agitation, anxiety
, blood pressure decreased, bronchospasm, cyanosis, fatigue, flushing, heart rate increased, hypoxia. Myozyme dosage: 350 MG, Q2W, INTRAVENOUS. During the same period patient was treated with BENADRYL, ACETAMINOPHEN, DECADRON. Patient recovered.Myozyme Side Effects Report #5102881-5
Myozyme side effect was reported by a Physician from KOREA, REPUBLIC OF on Aug 24, 2006. Female patient, 29 years of age, weighting 74.96 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: face oedema, flushing, gastric ulcer, infusion related reaction, pneumonia bacterial, pruritus, rash maculo-papular, tachycardia. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with RANITIDINE, TAZOBACTAM, ISEPAMICIN. Patient recovered.
Myozyme Side Effects Report #5425663-3
Myozyme side effect was reported by a Consumer or non-health professional from UNITED STATES on June 08, 2007. Female patient, 25 years of age, weighting 154.3 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: feeling hot, flushing. Myozyme dosage: 20 MG, KG, Q2WKS; IV. During the same period patient was treated with BIRTH CONTROL, HYDROCODONE BITARTRATE. Patient recovered.
Myozyme Side Effects Report #5566518-3
Myozyme side effect was reported by a Health Professional from UNITED STATES on Dec 05, 2007. Male patient, 22 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: arrhythmia
, asthenia, atrial fibrillation , blood potassium decreased, bundle branch block left, electrocardiogram st segment elevation, electrocardiogram t wave amplitude increased, flushing, palpitations. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.Myozyme Side Effects Report #5081199-3
Myozyme side effect was reported by a Physician from UNITED STATES on July 27, 2006. Male patient, 14 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure increased, bronchospasm, chest discomfort, chills, cyanosis, flushing, infusion related reaction, tachycardia, tachypnoea. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, BENADRYL, TYLENOL, STEROID. Patient recovered.
Myozyme Side Effects Report #5330164-7
Myozyme side effect was reported by a Health Professional from UNITED STATES on May 01, 2007. Male patient, 13 years of age, weighting 123.0 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure decreased, chest discomfort, flushing, hyperhidrosis, respiratory tract irritation, spinal disorder, supraventricular tachycardia, weight increased. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5205597-X
Myozyme side effect was reported by a Physician from UNITED STATES on Aug 17, 2006. Female patient, child 10 years of age, weighting 73.00 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: body temperature increased, flushing. Myozyme dosage: 25 MG/KG, Q2WKS; IV. During the same period patient was treated with ALPHA. Patient recovered.
Myozyme Side Effects Report #5285773-0
Myozyme side effect was reported by a Physician from UNITED STATES on Oct 31, 2006. Female patient, weighting 16.53 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: flushing, rash macular, urticaria. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA. Patient recovered.
Myozyme Side Effects Report #5160220-8
Myozyme side effect was reported by a Physician from UNITED STATES on Nov 06, 2006. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: condition aggravated, conjunctival hyperaemia, disease progression, erythema, flushing, hypertrophic cardiomyopathy, infusion related reaction, muscular weakness, nausea
. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.Myozyme Side Effects Report #6111696-0
Myozyme side effect was reported by a Pharmacist from UNITED STATES on Mar 10, 2009. Male patient, weighting 38.80 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anxiety
, flushing, hypotension, hypoxia, infusion related reaction, tachycardia. Myozyme dosage: 350 MG EVERY 2 WEEKS IV DRIP. Patient was hospitalized. Patient recovered.